Statement of Financial Position [Abstract] Total Current Assets Current assets Total Assets Total Liabilities Total Stockholders’ Deficiency Balance as of Balance as of Total Liabilities and Stockholders’ Deficiency Income Statement [Abstract] Total Operating Expenses Net Income (Loss) and Comprehensive Income (Loss) for the Period Net income (loss) for the period Net loss for the period Net loss Statement of Stockholders' Equity [Abstract] Balance as of (in Shares) Balance as of (in Shares) Equity Components [Axis] Statement of Cash Flows [Abstract] Cash used in operating activities Cash provided by financing activities (Decrease) Increase in Cash Cash, Beginning of Period Cash, End of Period Cash and cash equivalent Accounting Policies [Abstract] Accounting Standards Update and Change in Accounting Principle [Abstract] Long Term Investment [Abstract] Schedule of long term investments [Abstract] Property, Plant and Equipment [Abstract] Schedule of equipment [Abstract] Long-Lived Tangible Asset [Axis] Oil and Gas Property [Abstract] Schedule of acquisition mineral property interest [Abstract] Share-based Payment Arrangement [Abstract] Schedule of historical information about the Company's warrants [Abstract] Number of Warrants, beginning balance Number of Warrants, ending balance Number of Warrants Weighted Average Exercise Price, beginning balance (in Dollars per share) Weighted Average Exercise Price, ending balance (in Dollars per share) Schedule of warrants were outstanding and exercisable [Abstract] Award Date [Axis] Schedule of incentive stock options [Abstract] Number of options, Outstanding at beginning Number of options, Outstanding at ending Weighted Average Exercise Price, Outstanding at beginning Weighted Average Exercise Price, Outstanding at ending Fair Value Disclosures [Abstract] Schedule of fair value of assets [Abstract] Fair Value Hierarchy and NAV [Axis] Schedule of financial liabilities measured at fair value [Abstract] Due To Shareholder [Abstract] Debt Disclosure [Abstract] Schedule of convertible debt and associated financial instruments based on their relative fair values [Abstract] Total proceeds Schedule of carrying value of the convertible notes [Abstract] Convertible debenture – beginning of the period Carrying value – end of the period Commitments and Contingencies Disclosure [Abstract] Related Party Transactions [Abstract] Schedule of expenses with related parties [Abstract] Related Party Transaction [Axis] Schedule of the Company was indebted to its related parties [Abstract] Geographical Area Information [Abstract] Schedule of assets and liabilities by geographical area [Abstract] Geographical [Axis] Subsequent Events [Abstract] Document Type Document Period End Date Entity File Number Entity Incorporation, State or Country Code Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Entity Central Index Key Entity Registrant Name ASSETS Current Assets Prepaid expenses Long term investments (Note 4) Equipment (Note 5) Carrying amounts LIABILITIES Current Liabilities Accounts payable and accrued liabilities (Note 12) Due to shareholder (Note 9) Due to shareholder Loan payable Convertible debenture (Note 10) Loan interest payable (Note 10) STOCKHOLDERS’ DEFICIENCY Common Stock (Note 7) - 400,000,000 authorized - 264,541,664 issued (March 31, 2020 – 144,647,664) Common stock, shares authorized Common stock, shares issued Additional Paid-in Capital Contributed Surplus Deficit Incurred cumulative losses Operating Expenses Consulting and professional fees (Note 12) Default penalties (Note 7) Exploration (Note 6) Office and administration fees Travel Other Expenses Loss on investment in warrants Unrealized gain (loss) on investment in common shares (Note 4) Unrealized Gain (Loss) on Derivatives Income (Loss) Per Common Share (in Dollars per share) Weighted Average Number of Shares Outstanding – Basic and diluted (in Shares) Commitment shares issued Issuance of 6,514,350 common shares Commitment shares issued (in Shares) Warrants exercised Warrants exercised (in Shares) Warrants issued Convertible debenture - equity portion Principal of convertible debenture Convertible debenture -converted to shares Convertible debenture -converted to shares (in Shares) Convertible debenture – default penalty shares Convertible debenture – default penalty shares (in Shares) CASH PROVIDED BY (USED IN): OPERATING ACTIVITIES Non-cash items: Default penalties Accretion Interest accrued on convertible debenture Convertible debenture transaction costs Changes in non-cash working capital: Accounts payable and accrued liabilities Due to shareholder FINANCING ACTIVITIES Proceeds from convertible debenture Supplemental disclosure of cash flow information Cash paid for interest Cash paid for taxes Issuance of common stock for loan interest payable Foreign exchange Interest expenses (Note 10) Accretion (Note 10) Debt issuance cost – cash (Note 10) Loss on investment in warrants Unrealized (gain) loss on investment in common shares Prepaid expenses Convertible debenture transaction costs Common Stock Common Shares [Member] Additional Paid-in Capital Contributed Surplus Deficit Description of Business Basis of Presentation Recent Accounting Pronouncements Long Term Investments Schedule of long term investments Number (in Shares) Fair Value Total investment: Equipment Schedule of equipment Cost Cost Accumulated Depreciation Accumulated Depreciation Carrying amounts Mineral Property Interest Schedule of acquisition mineral property interest Acquisition of mineral property interest Cash payment Balance, March 31 & September 30, 2020 Common Stock Schedule of warrants were outstanding and exercisable Weighted Average Life Remaining (Years), beginning balance Debt instrument term Number of Warrants, warrants issued Warrants issued (in Shares) Weighted Average Exercise Price, warrants issued (in Dollars per share) Number of Warrants, warrants exercised Weighted Average Exercise Price, warrants exercised (in Dollars per share) Number of Warrants, warrants cancelled Warrants cancelled Weighted Average Life Remaining (Years), ending balance Schedule of warrants were outstanding and exercisable Exercise Price (in Dollars per share) Warrants Exercise Price (in Dollars per share) Exercise price (in Dollars per share) Expiry Date Schedule of incentive stock options Weighted Average Life Remaining (Years), Outstanding at beginning Weighted Average Exercise Price, Cancelled Fair Value of Financial Instruments Schedule of fair value of assets Long-term investment – Shares Total Schedule of financial liabilities measured at fair value Accounts payable Due to shareholder Loan payable Convertible debt Total